Foundation Board approves funding for largest multi-country CIDP research ever
Chronic inflammatory demyelinating polyneuropathy (CIDP) is such a remarkably heterogeneous disorder – one with diverse presentations, a highly variable disease course, and differing, often unpredictable treatment responses. Neurologist-researchers around the…
Persons who have previously had GBS may receive an mRNA COVID-19 vaccine
Please see the full article at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/underlying-conditions.html
An Open Letter to Dr. A.S. Fauci, Director NIAID, NIH
(Please see the following open letter statement authored by members of the GBS|CIDP Foundation International medical community as referenced.) As clinician/scientists who have spent careers studying GBS, we are concerned…
Running to Raise Awareness and Fundraising for GBS CIDP Foundation International
On November 14th, João Mateus, a 33-year-old Portuguese fund manager and marathon runner, paid tribute to his grandmother, Maria Manuela Mateus – loved and cherished by all. Manuela Mateus was…
Dr. Bart Jacobs, Vice Chairman of GMAB, and co-authors, “Editor’s Choice,” Brain Journal
Regional variation of Guillain-Barré syndrome Brain, Volume 141, Issue 10, 1 October 2018, Pages 2866–2877 An article published in Brain Journal, September 25, 2018, regarding research findings of the International…